Thalassemia Treatment Based on the Stem Cell Technology
NCT03222453
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
2
Enrollment
OTHER
Sponsor class
Conditions
Beta-Thalassemia
Interventions
BIOLOGICAL:
Hematopoetic stem cells
Sponsor
Xiaofang Sun
Collaborators
[object Object]
[object Object]
[object Object]